(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine

C52H50F6N12O2 — CID 158854419

IUPAC(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
SMILESCCOc1nc(/C=C/c2nc3n(n2)CCC[C@@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1.CCOc1nc(/C=C/c2nc3n(n2)CCC[C@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1
InChIInChI=1S/2C26H25F3N6O/c2*1-3-36-25-22(34-15-17(2)30-16-34)12-10-20(31-25)11-13-23-32-24-21(5-4-14-35(24)33-23)18-6-8-19(9-7-18)26(27,28)29/h2*6-13,15-16,21H,3-5,14H2,1-2H3/b2*13-11+/t2*21-/m10/s1
InChIKeyIZWADZQJAJREKI-URLFIWADSA-N
MW989.04 g/mol
LogP11.36
Rot. Bonds12

About (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine

(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine (PubChem CID 158854419) has the molecular formula C52H50F6N12O2 and a molecular weight of 989.04 g/mol. Its IUPAC name is (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine.

Molecular Properties

Compound Name(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
PubChem CID158854419
Molecular FormulaC52H50F6N12O2
Molecular Weight989.04 g/mol
Exact Mass988.41
IUPAC Name(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine
SMILESCCOc1nc(/C=C/c2nc3n(n2)CCC[C@@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1.CCOc1nc(/C=C/c2nc3n(n2)CCC[C@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1
InChIInChI=1S/2C26H25F3N6O/c2*1-3-36-25-22(34-15-17(2)30-16-34)12-10-20(31-25)11-13-23-32-24-21(5-4-14-35(24)33-23)18-6-8-19(9-7-18)26(27,28)29/h2*6-13,15-16,21H,3-5,14H2,1-2H3/b2*13-11+/t2*21-/m10/s1
InChIKeyIZWADZQJAJREKI-URLFIWADSA-N
XLogP11.36
TPSA141.30 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500989.04
LogP ≤ 511.36
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The IUPAC name of (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine (CID 158854419) is (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine.
What is the SMILES notation for (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The canonical SMILES for (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine is CCOc1nc(/C=C/c2nc3n(n2)CCC[C@@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1.CCOc1nc(/C=C/c2nc3n(n2)CCC[C@H]3c2ccc(C(F)(F)F)cc2)ccc1-n1cnc(C)c1.
What is the InChIKey of (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
The InChIKey is IZWADZQJAJREKI-URLFIWADSA-N. The full InChI is InChI=1S/2C26H25F3N6O/c2*1-3-36-25-22(34-15-17(2)30-16-34)12-10-20(31-25)11-13-23-32-24-21(5-4-14-35(24)33-23)18-6-8-19(9-7-18)26(27,28)29/h2*6-13,15-16,21H,3-5,14H2,1-2H3/b2*13-11+/t2*21-/m10/s1.
What are the key properties of (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine?
(8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine has a molecular weight of 989.04 g/mol, XLogP of 11.36, 12 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (8S)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine;(8R)-2-[(E)-2-[6-ethoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]ethenyl]-8-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine is sourced from PubChem (CID 158854419), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).